Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs MARKSANS PHARMA. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. MARKSANS PHARMA. GENNEX LAB./
MARKSANS PHARMA.
 
P/E (TTM) x 35.0 21.5 162.8% View Chart
P/BV x 4.5 3.9 114.4% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 GENNEX LAB.   MARKSANS PHARMA.
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
MARKSANS PHARMA.
Mar-23
GENNEX LAB./
MARKSANS PHARMA.
5-Yr Chart
Click to enlarge
High Rs974 12.2%   
Low Rs539 12.4%   
Sales per share (Unadj.) Rs3.440.9 8.2%  
Earnings per share (Unadj.) Rs0.35.9 4.8%  
Cash flow per share (Unadj.) Rs0.37.0 4.7%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.9 0.0%  
Book value per share (Unadj.) Rs4.538.5 11.8%  
Shares outstanding (eoy) m176.64453.16 39.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.11.4 149.6%   
Avg P/E ratio x25.09.7 258.4%  
P/CF ratio (eoy) x21.08.1 260.3%  
Price / Book Value ratio x1.51.5 104.1%  
Dividend payout %08.5 0.0%   
Avg Mkt Cap Rs m1,22925,631 4.8%   
No. of employees `000NANA-   
Total wages/salary Rs m792,394 3.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m59318,521 3.2%  
Other income Rs m40593 6.7%   
Total revenues Rs m63319,115 3.3%   
Gross profit Rs m473,393 1.4%  
Depreciation Rs m9519 1.8%   
Interest Rs m1491 14.8%   
Profit before tax Rs m643,377 1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15723 2.0%   
Profit after tax Rs m492,653 1.9%  
Gross profit margin %7.918.3 43.2%  
Effective tax rate %22.821.4 106.4%   
Net profit margin %8.314.3 57.9%  
BALANCE SHEET DATA
Current assets Rs m48716,997 2.9%   
Current liabilities Rs m2953,654 8.1%   
Net working cap to sales %32.372.0 44.8%  
Current ratio x1.64.7 35.5%  
Inventory Days Days46 70.9%  
Debtors Days Days57,912,58982 70,498,203.7%  
Net fixed assets Rs m8355,246 15.9%   
Share capital Rs m180453 39.8%   
"Free" reserves Rs m62316,998 3.7%   
Net worth Rs m80417,452 4.6%   
Long term debt Rs m1630-   
Total assets Rs m1,32222,242 5.9%  
Interest coverage x5.738.0 15.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.40.8 53.9%   
Return on assets %4.712.3 38.5%  
Return on equity %6.115.2 40.3%  
Return on capital %8.019.9 40.2%  
Exports to sales %42.10-   
Imports to sales %13.67.3 186.7%   
Exports (fob) Rs m250NA-   
Imports (cif) Rs m811,348 6.0%   
Fx inflow Rs m2506,491 3.9%   
Fx outflow Rs m861,348 6.4%   
Net fx Rs m1645,143 3.2%   
CASH FLOW
From Operations Rs m2372,374 10.0%  
From Investments Rs m-383-2,592 14.8%  
From Financial Activity Rs m2101,978 10.6%  
Net Cashflow Rs m641,760 3.6%  

Share Holding

Indian Promoters % 23.6 43.9 53.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 20.3 -  
FIIs % 0.0 15.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 56.2 136.1%  
Shareholders   69,723 237,377 29.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs MARKSANS PHARMA.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs MARKSANS PHARMA. Share Price Performance

Period GENNEX LABORATORIES MARKSANS PHARMA. S&P BSE HEALTHCARE
1-Day 1.35% 0.46% 1.18%
1-Month -13.90% -0.72% -0.75%
1-Year 189.91% 109.61% 61.82%
3-Year CAGR 62.78% 45.11% 18.16%
5-Year CAGR 40.09% 43.62% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the MARKSANS PHARMA. share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of MARKSANS PHARMA. the stake stands at 43.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of MARKSANS PHARMA..

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

MARKSANS PHARMA. paid Rs 0.5, and its dividend payout ratio stood at 8.5%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of MARKSANS PHARMA..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.